Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Medbanks Closes $305 Million Financing for China Oncology Mega-Data

publication date: Dec 30, 2020

Medbanks Network Technology completed a $305 million Series E1 round led by Tencent and Jeneration Capital. Medbanks is a Beijing-headquartered big data medical and healthcare services provider, specializing in oncology. The company helps researchers, clinicians and pharmas with data, helping pharmaceutical firms coordinate clinical trials for new drug and clinicians find the right treatment for a patient's particular cancer. Tencent has now participated in five Medbanks rounds. More details....

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital